Skip to main content
MedPacto, Inc. logo

MedPacto, Inc. — Investor Relations & Filings

Ticker · 235980 ISIN · KR7235980000 KO Manufacturing
Filings indexed 262 across all filing types
Latest filing 2023-03-28 Board/Management Inform…
Country KR South Korea
Listing KO 235980

About MedPacto, Inc.

http://www.medpacto.com/eng/

MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of first-in-class therapies. The company leverages a biomarker-driven and genome-based platform to create personalized treatments, aiming to advance precision medicine. Its primary therapeutic areas include oncology and autoimmune diseases, with pipeline expansion into metabolic and bone joint disorders. MedPacto's research focuses on novel mechanisms, such as modulating the tumor microenvironment, to address incurable diseases and overcome the limitations of existing treatments.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment of an outside director (사외이사). It details the specific individual appointed, their background, and the change in board composition. This falls under the category of board and management changes.
2023-03-28 Korean
[기재정정]정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal report of the results of an Annual General Meeting (AGM) for the company MedPacto, dated 2023-03-28. It details the voting results on agenda items such as financial statement approval, director appointments, and business purpose changes. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-03-28 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the fiscal year 2022 (Jan 1, 2022 - Dec 31, 2022) for MedPacto, Inc. It contains detailed information on company overview, history, capital structure, governance, and business operations, including detailed descriptions of their drug pipeline (Vactosertib). This is the standard Korean regulatory filing equivalent to an Annual Report (10-K). FY 2022
2023-03-14 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal announcement titled '감사보고서 제출' (Submission of Audit Report) filed by MedPacto. It provides a summary of the audit opinion (unqualified/appropriate), key financial data (assets, liabilities, equity, profit/loss), and details regarding the auditor. While it contains financial data, it is a regulatory disclosure announcing the completion and submission of the audit report to the exchange, rather than the full annual report itself. Therefore, it fits the definition of a Report Publication Announcement (RPA). FY 2022
2023-03-13 Korean
기타경영사항(자율공시)(특허권 취득)
Regulatory Filings Classification · 100% confidence The document is a voluntary disclosure (자율공시) from MedPacto regarding the acquisition of a patent for a TGF-β inhibitor manufacturing process. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general regulatory announcement regarding corporate business developments (patent acquisition), it falls under the fallback category for regulatory filings.
2023-03-09 Korean
[기재정정]기타경영사항(자율공시)(특허권 취득)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from MedPacto regarding a patent acquisition (TGF-β inhibitor manufacturing method). It is categorized as a 'voluntary disclosure' (자율공시) under Korean regulatory standards. Since it does not fit into specific categories like financial reports, dividends, or management changes, and is a formal regulatory announcement of a corporate event, it falls under the 'Regulatory Filings' category.
2023-03-09 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.